Stimulation of postsynaptic D2− dopamine receptors by B‐HT 958 is revealed by co‐treatment with the D1− receptor agonist SKF 38393

Abstract— The motor activity of reserpine‐treated mice was used to study effects of B‐HT958 (2‐amino‐6‐(p‐chlorobenzyl)‐4H‐5,6, 7, 8‐tetrahydrothiazolo‐[5, 4‐d]‐azepine) on postsynaptic dopamine and noradrenaline receptors. The motor activity was only slightly stimulated by B‐HT 958 or by the D1− receptor agonist SKF 38393 but it was markedly increased by the two drugs given in combination. The effect of B‐HT 958 peaked earlier following low rather than high doses. The enhanced motor activity was inhibited by the D2− receptor antagonist sulpiride or the D1− receptor antagonist SCH 23390, indicating that it was caused by stimulation of both receptor types. The results suggest that B‐HT 958 stimulates postsynaptic D2− receptors in addition to D2− autoreceptors and that its blockade of postsynaptic α2‐adrenoceptors is of no importance for the motor activity.

[1]  N. Andén,et al.  Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors. , 1988, Acta physiologica Scandinavica.

[2]  F. Ferrari,et al.  Imidazole and yohimbine antagonize hypomotility, penile erection, stretching and yawning induced in rats by BHT 920, a selective dopamine autoreceptor agonist. , 1988, Pharmacological research communications.

[3]  O. Hornykiewicz,et al.  Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation. , 1988, European journal of pharmacology.

[4]  F. J. White,et al.  B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence. , 1988, Life sciences.

[5]  N. Andén,et al.  Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptors. , 1987, Acta physiologica Scandinavica.

[6]  N. Andén,et al.  Inhibitory role of D‐1 dopamine receptors for the jerks induced by B‐HT 920 in rats , 1987, The Journal of pharmacy and pharmacology.

[7]  J. Hyttel,et al.  Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. , 1987, European journal of pharmacology.

[8]  F. J. White,et al.  Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications , 1987 .

[9]  T. Chase,et al.  Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. , 1986, European journal of pharmacology.

[10]  O. Hornykiewicz,et al.  The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. , 1986, European journal of pharmacology.

[11]  J. Waddington Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems. , 1986, Biochemical pharmacology.

[12]  O. Hornykiewicz,et al.  B-HT 958--an antagonist at alpha 2-adrenoceptors and an agonist at dopamine autoreceptors in the brain. , 1984, European journal of pharmacology.

[13]  N. Andén,et al.  B‐HT 958 stimulates dopamine autoreceptors but blocks noradrenaline autoreceptors in the brain , 1984, The Journal of pharmacy and pharmacology.

[14]  N. Andén,et al.  Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain. , 2009, Acta pharmacologica et toxicologica.

[15]  L. Pichler,et al.  Investigation into different types of post- and presynaptic alpha-adrenoceptors at cardiovascular sites in rats. , 1980, European journal of pharmacology.

[16]  T. Svensson,et al.  Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity. , 1974, Brain research.